Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination

Por um escritor misterioso
Last updated 20 setembro 2024
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation - ScienceDirect
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients, BMC Medicine
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Vaccines, Free Full-Text
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice - eBioMedicine
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Frontiers mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Frontiers Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
PDF) IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Repeated SARS-CoV-2 mRNA vaccination increased IgG4 level
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Kilian Schober on X: We observed an unexpected rise in IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. This work is now published @SciImmunology. The 🧵👇 will point to my tweetorial of
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
Exploration of factors correlated with Long COVID
Class switch toward noninflammatory, spike-specific IgG4 antibodies after  repeated SARS-CoV-2 mRNA vaccination
The appearance of anti-spike RBD IgG4 responses after repetitive immunization with mRNA-based COVID-19 vaccines - ScienceDirect

© 2014-2024 acecr-tums.ir. All rights reserved.